Ana-maria M. Orbai

Ana-maria M. Orbai

Rheumatology

Bayview Medical Offices, Level 01 (G), Clinic 5
Baltimore, MD 21224

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 117 publications

Granulomatosis with polyangiitis following Lyme disease.

Granulomatosis with polyangiitis following Lyme disease.

Journal: The American journal of medicine

Published: May 07, 2026

Control of Inflammation and Sustained Improvements in Patient-Reported Outcomes in Patients With Psoriatic Arthritis: Bimekizumab Two-Year Results From Two Phase 3 Studies.

Control of Inflammation and Sustained Improvements in Patient-Reported Outcomes in Patients With Psoriatic Arthritis: Bimekizumab Two-Year Results From Two Phase 3 Studies.

Journal: ACR open rheumatology

Published: October 27, 2025

Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis.

Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis.

Journal: Annals of the rheumatic diseases

Published: October 19, 2025

Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024.

Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024.

Journal: The Journal of rheumatology

Published: August 21, 2025

Intravenous immunoglobulin as a treatment for severe, refractory cutaneous lupus erythematosus requiring hospitalization: Three cases and review of the literature.

Intravenous immunoglobulin as a treatment for severe, refractory cutaneous lupus erythematosus requiring hospitalization: Three cases and review of the literature.

Journal: Lupus

Published: July 07, 2025

Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024.

Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024.

Journal: The Journal of rheumatology

Published: March 09, 2025

Estimating the incidence of autoimmune inflammatory arthritis after Lyme disease.

Estimating the incidence of autoimmune inflammatory arthritis after Lyme disease.

Journal: Seminars in arthritis and rheumatism

Published: February 14, 2025

Determining the best discriminatory physical functioning outcome measurement instrument for psoriatic arthritis trials: A meta-epidemiological study.

Determining the best discriminatory physical functioning outcome measurement instrument for psoriatic arthritis trials: A meta-epidemiological study.

Journal: Seminars in arthritis and rheumatism

Published: January 05, 2025

Association Between Patient Perception of Disease Status and Different Components of the Minimal Disease Activity Criteria in Psoriatic Arthritis.

Association Between Patient Perception of Disease Status and Different Components of the Minimal Disease Activity Criteria in Psoriatic Arthritis.

Journal: The Journal of rheumatology

Published: December 27, 2024

Anti-PCNA antibodies in psoriatic arthritis: a case-control study.

Anti-PCNA antibodies in psoriatic arthritis: a case-control study.

Journal: Rheumatology advances in practice

Published: December 17, 2024

Development of a Personalized Visualization and Analysis Tool to Improve Clinical Care in Complex Multisystem Diseases With Application to Scleroderma.

Development of a Personalized Visualization and Analysis Tool to Improve Clinical Care in Complex Multisystem Diseases With Application to Scleroderma.

Journal: Arthritis care & research

Published: September 27, 2024

Long-term safety of bimekizumab in adult patients with axial spondyloarthritis or psoriatic arthritis: pooled results from integrated phase IIb/III clinical studies.

Long-term safety of bimekizumab in adult patients with axial spondyloarthritis or psoriatic arthritis: pooled results from integrated phase IIb/III clinical studies.

Journal: RMD open

Published: September 20, 2024

Showing 1-12 of 117

Last Updated: 09/26/2026